Our Blog – What moves us

Again: Bunnies in for a rough ride

Again: Bunnies in for a rough ride

Another bad day for bunnies. This time it was the purple milk bunny and for a change it was not about the infringement of trademark rights, but about a violation of the labeling obligation for food, which the judges at the Bremen Regional Court had to decide on (12 O...

mehr lesen
There can be only one … gold chocolate bunny

There can be only one … gold chocolate bunny

With more than 500 million sold over the past three decades and a market share of over 40 percent (2017), the chocolate bunny in gold foil, red bow and bell is the clear market leader. But there can be no talk of post-Easter peace. Bad karma for gold bunnies in the...

mehr lesen
COVID variants and vaccination: A race against time

COVID variants and vaccination: A race against time

The COVID-19 pandemic has reached its first-year anniversary in recent days. With sad milestones such as almost 3 million deaths and far over 100 million reported infections, we are just starting to process the dire consequences this disease has not only on our...

mehr lesen
Intel becomes victim of patent trolls

Intel becomes victim of patent trolls

Dubious business model Patent trolls are well-funded companies that have no research and development of their own and whose business model is to buy up patents at low prices and then try to enforce them against alleged (or actual) infringers. Last year, for example,...

mehr lesen
Molnupiravir: The next cure for Cov-2?

Molnupiravir: The next cure for Cov-2?

Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug originally developed by Emory University for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral effect...

mehr lesen
Smart cars for ECJ

Smart cars for ECJ

The patent dispute between Nokia and Daimler concerning alleged infringement of various mobile communications patents will now step to the ECJ. On Thursday December 17, 2020 the Düsseldorf Regional Court (LG) announced submitting several questions to the ECJ...

mehr lesen
Union trademarks in the UK after Brexit

Union trademarks in the UK after Brexit

The Brexit becomes effective At the end of the year, the transitional period expires and the Brexit becomes effective. Recently, the rules for the extension of Union trademarks to the UK have been clarified: 1. All Union trademarks.. registered or to be registered by...

mehr lesen
mRNA Corona vaccines: A step towards normality

mRNA Corona vaccines: A step towards normality

The second Corona wave As the second Corona wave is accelerating in Europe and the US, thereby forcing us again to restrict our social interaction to a bare minimum, the announcements in recent days by Pfizer/BioNTech and Moderna of highly effective vaccines...

mehr lesen
Our chance to control the pandemic globally

Our chance to control the pandemic globally

Controlling COVID19 infections is essential to prevent further damage to society and the collapse of health care systems. PCR-based methods have been the gold standard testing approach for the first phase of this pandemic. However, low throughput, high costs and long...

mehr lesen
NO FLOWERS FOR THE “FLOWER THROWER”

NO FLOWERS FOR THE “FLOWER THROWER”

Anonymous Street-Art artist lost TM protection for one of his most iconic motifs for allegedly having filed the mark in bad faith. Banksy is certainly one of the hottest artists of our time. His Street-Art artworks suddenly appear in the most unusual places. The...

mehr lesen
ADLON STAYS EXCLUSIVELY WITH KEMPINSKY

ADLON STAYS EXCLUSIVELY WITH KEMPINSKY

The brand „Adlon“ remains exclusively reserved for the Berlin luxury hotel Adlon Kempinski. The first instance court of the European Union (EuG) in Luxembourg dismissed a complaint of the sanitary products manufacturer Kludi on Wednesday, which wanted to sell bathroom...

mehr lesen
PATENT TROLLS SUCCESSFUL AGAINST APPLE

PATENT TROLLS SUCCESSFUL AGAINST APPLE

According to a recent decision of a US court in Texas, technology giant Apple has infringed five patents hold by Optis Wireless Technology and was sentenced in the first instance to pay damages of at least half a billion dollar. Apple has announced taking the decision...

mehr lesen

Our Authors

Bernd Fabry is founder and CEO of IP2. He is a qualified German and European Patent and Trademark Attorney. He has more than 25 years company experience as Head of IP departments. 

Dr. Bernd Fabry - CEO

We are pleased that our Scientific Adviser, Dr. Martin Fabry from the University of Cambridge, will now report regularly on new developments in this exciting field.

Dr. Martin Fabry - Scientific Advisor

Subscribe to our newsletter!

Never miss the newest blog post or important information about patents and laws